Daniel F. Saragiotto
Tapirai, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prognostic Impact of Primary Tumor Sidedness in Stage III Colorectal Cancer: Real-World Evidence from a Brazilian Cohort.
Journal: Clinical colorectal cancer
Published: August 18, 2023
Malignant bowel obstruction: effectiveness and safety of systemic chemotherapy.
Journal: BMJ supportive & palliative care
Published: August 24, 2020
Conversion Chemotherapy With a Modified FLOX Regimen for Borderline or Unresectable Liver Metastases From Colorectal Cancer: An Alternative for Limited-Resources Settings.
Journal: Journal of global oncology
Published: September 04, 2019
Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the Community.
Journal: Clinical colorectal cancer
Published: December 21, 2015
Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 12, 2014
Modified FLOX as first-line chemotherapy for metastatic colorectal cancer patients in the public health system in Brazil: Effectiveness and cost-utility analysis.
Journal: Molecular and clinical oncology
Published: May 18, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026